167 related articles for article (PubMed ID: 32225033)
1. Sex-Related Differences of the Effect of Lipoproteins and Apolipoproteins on 10-Year Cardiovascular Disease Risk; Insights from the ATTICA Study (2002-2012).
Kouvari M; Panagiotakos DB; Chrysohoou C; Georgousopoulou EN; Tousoulis D; Pitsavos AC
Molecules; 2020 Mar; 25(7):. PubMed ID: 32225033
[TBL] [Abstract][Full Text] [Related]
2. Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study.
Nomikos T; Panagiotakos D; Georgousopoulou E; Metaxa V; Chrysohoou C; Skoumas I; Antonopoulou S; Tousoulis D; Stefanadis C; Pitsavos C;
Lipids Health Dis; 2015 Sep; 14():108. PubMed ID: 26370413
[TBL] [Abstract][Full Text] [Related]
3. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.
Ridker PM; Rifai N; Cook NR; Bradwin G; Buring JE
JAMA; 2005 Jul; 294(3):326-33. PubMed ID: 16030277
[TBL] [Abstract][Full Text] [Related]
4. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
[TBL] [Abstract][Full Text] [Related]
5. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins.
Mahley RW; Palaoğlu KE; Atak Z; Dawson-Pepin J; Langlois AM; Cheung V; Onat H; Fulks P; Mahley LL; Vakar F
J Lipid Res; 1995 Apr; 36(4):839-59. PubMed ID: 7616127
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
[TBL] [Abstract][Full Text] [Related]
7. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
Castañer O; Pintó X; Subirana I; Amor AJ; Ros E; Hernáez Á; Martínez-González MÁ; Corella D; Salas-Salvadó J; Estruch R; Lapetra J; Gómez-Gracia E; Alonso-Gomez AM; Fiol M; Serra-Majem L; Corbella E; Benaiges D; Sorli JV; Ruiz-Canela M; Babió N; Sierra LT; Ortega E; Fitó M
J Am Coll Cardiol; 2020 Dec; 76(23):2712-2724. PubMed ID: 33272365
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
Lamprea-Montealegre JA; Staplin N; Herrington WG; Haynes R; Emberson J; Baigent C; de Boer IH;
Clin J Am Soc Nephrol; 2020 Jan; 15(1):47-60. PubMed ID: 31831577
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein (a) and 10-year Cardiovascular Disease Incidence in Apparently Healthy Individuals: A Sex-based Sensitivity Analysis from ATTICA Cohort Study.
Kouvari M; Panagiotakos DB; Chrysohoou C; Georgousopoulou EN; Yannakoulia M; Tousoulis D; Pitsavos C
Angiology; 2019 Oct; 70(9):819-829. PubMed ID: 31185726
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
[TBL] [Abstract][Full Text] [Related]
11. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.
Mora S; Rifai N; Buring JE; Ridker PM
Circulation; 2008 Sep; 118(10):993-1001. PubMed ID: 18711012
[TBL] [Abstract][Full Text] [Related]
12. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
[TBL] [Abstract][Full Text] [Related]
13. Association between lipids and apolipoproteins on type 2 diabetes risk; moderating effects of gender and polymorphisms; the ATTICA study.
Mellor DD; Georgousopoulou EN; D'Cunha NM; Naumovski N; Chrysohoou C; Tousoulis D; Pitsavos C; Panagiotakos DB;
Nutr Metab Cardiovasc Dis; 2020 May; 30(5):788-795. PubMed ID: 32127339
[TBL] [Abstract][Full Text] [Related]
14. Major lipids, apolipoproteins, and risk of vascular disease.
; Di Angelantonio E; Sarwar N; Perry P; Kaptoge S; Ray KK; Thompson A; Wood AM; Lewington S; Sattar N; Packard CJ; Collins R; Thompson SG; Danesh J
JAMA; 2009 Nov; 302(18):1993-2000. PubMed ID: 19903920
[TBL] [Abstract][Full Text] [Related]
15. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.
Mora S; Buring JE; Ridker PM; Cui Y
Ann Intern Med; 2011 Dec; 155(11):742-50. PubMed ID: 22147713
[TBL] [Abstract][Full Text] [Related]
16. Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002-2012).
Georgoulis M; Chrysohoou C; Georgousopoulou E; Damigou E; Skoumas I; Pitsavos C; Panagiotakos D
Lipids Health Dis; 2022 Dec; 21(1):141. PubMed ID: 36529737
[TBL] [Abstract][Full Text] [Related]
17. Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.
Pechlaner R; Tsimikas S; Yin X; Willeit P; Baig F; Santer P; Oberhollenzer F; Egger G; Witztum JL; Alexander VJ; Willeit J; Kiechl S; Mayr M
J Am Coll Cardiol; 2017 Feb; 69(7):789-800. PubMed ID: 28209220
[TBL] [Abstract][Full Text] [Related]
18. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
Oyelola OO
Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671
[TBL] [Abstract][Full Text] [Related]
19. Sex and time differences in the associations of non-high-density lipoprotein cholesterol versus other lipid and lipoprotein factors in the prediction of cardiovascular death (The Rancho Bernardo Study).
von Mühlen D; Langer RD; Barrett-Connor E
Am J Cardiol; 2003 Jun; 91(11):1311-5. PubMed ID: 12767422
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men.
Clarke R; Emberson JR; Parish S; Palmer A; Shipley M; Linksted P; Sherliker P; Clark S; Armitage J; Fletcher A; Collins R
Arch Intern Med; 2007 Jul; 167(13):1373-8. PubMed ID: 17620530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
